Finn RD - Search Results

1

Gallium-transferrin as a macromolecular tracer of vascular permeability.

Brunetti A, Blasberg RG, Finn RD, Larson SM. Brunetti A, et al. Among authors: finn rd. Int J Rad Appl Instrum B. 1988;15(6):665-72. doi: 10.1016/0883-2897(88)90059-1. Int J Rad Appl Instrum B. 1988. PMID: 3266964

2

Synthesis of a fluorinated fatty acid, dl-erythro-9,10-[18F]difluoropalmitic acid, and biodistribution studies in rats.

Schmall B, Finn RD, Rapoport SI, Noronha JG, DeGeorge JJ, Kiesewetter DO, Simpson NR, Larson SM. Schmall B, et al. Among authors: finn rd. Int J Rad Appl Instrum B. 1990;17(8):805-9. doi: 10.1016/0883-2897(90)90029-z. Int J Rad Appl Instrum B. 1990. PMID: 2079427

3

Comparison of iron-59, indium-111, and gallium-69 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor.

Otsuki H, Brunetti A, Owens ES, Finn RD, Blasberg RG. Otsuki H, et al. Among authors: finn rd. J Nucl Med. 1989 Oct;30(10):1676-85. J Nucl Med. 1989. PMID: 2795208 Free article.

4

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

Ugur O, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ugur O, et al. Among authors: finn rd. Nucl Med Biol. 2002 Feb;29(2):147-57. doi: 10.1016/s0969-8051(01)00290-6. Nucl Med Biol. 2002. PMID: 11823119

5

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.

Ruan S, O'Donoghue JA, Larson SM, Finn RD, Jungbluth A, Welt S, Humm JL. Ruan S, et al. Among authors: finn rd. J Nucl Med. 2000 Nov;41(11):1905-12. J Nucl Med. 2000. PMID: 11079503 Free article.

6

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

Lövqvist A, Humm JL, Sheikh A, Finn RD, Koziorowski J, Ruan S, Pentlow KS, Jungbluth A, Welt S, Lee FT, Brechbiel MW, Larson SM. Lövqvist A, et al. Among authors: finn rd. J Nucl Med. 2001 Aug;42(8):1281-7. J Nucl Med. 2001. PMID: 11483692 Free article.

7

Metabolic imaging of human extremity musculoskeletal tumors by PET.

Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, Finn RD, Rosenberg SA, Larson SM. Kern KA, et al. Among authors: finn rd. J Nucl Med. 1988 Feb;29(2):181-6. J Nucl Med. 1988. PMID: 2831318 Free article.

8

Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.

Brunetti A, Berg G, Di Chiro G, Cohen RM, Yarchoan R, Pizzo PA, Broder S, Eddy J, Fulham MJ, Finn RD, et al. Brunetti A, et al. Among authors: finn rd. J Nucl Med. 1989 May;30(5):581-90. J Nucl Med. 1989. PMID: 2785582 Free article.

9

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

Larson SM, Carrasquillo JA, Colcher DC, Yokoyama K, Reynolds JC, Bacharach SA, Raubitchek A, Pace L, Finn RD, Rotman M, et al. Larson SM, et al. Among authors: finn rd. J Nucl Med. 1991 Sep;32(9):1661-7. J Nucl Med. 1991. PMID: 1880565 Free article.

10

In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.

Scott AM, Rosa E, Mehta BM, Divgi CR, Finn RD, Biedler JL, Tsuruo T, Kalaigian H, Larson SM. Scott AM, et al. Among authors: finn rd. Nucl Med Biol. 1995 May;22(4):497-504. doi: 10.1016/0969-8051(94)00127-6. Nucl Med Biol. 1995. PMID: 7550027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters